|国家预印本平台
首页|高精度腹腔灌注化疗患者血清中miR-409-3p表达水平与胃癌预后的关系

高精度腹腔灌注化疗患者血清中miR-409-3p表达水平与胃癌预后的关系

中文摘要英文摘要

目的探讨高精度腹腔灌注化疗(HIPEC)治疗后血清miR-409-3P表达水平与胃癌预后的关系。方法采用实时荧光定量聚合酶链反应检测高精度腹腔灌注化疗后血清miR-409-3p表达水平,并分析其胃癌预后的关系。结果高精度腹腔灌注化疗后血清miR-409-3p低表达量组中位生存期低于高表达量组中位生存期,差异认为有统计学意义。结论血清miR-409-3p可能成为评估预后的生物标志物

Objective To investigate the relationship between expression levels of serum miR-409-3P after HyperthemicIntraperitoneal Chemotherapy (HIPEC) and prognosis of gastric cancer. Methods The serum expression levels of miR-409-3pafter HIPEC was examined using real-time reverse transcription polymerase chain reaction and analyze the relationshipbetween levels and prognosis of gastric cancer. Results The high expression group tended to have longer median survivaltime, compared with the low expression group, P=0.003. Conclusion The expression levels of serum miR-409-3P after HIPECmay become biomarkers of evaluate prognostic of gastric cancer.

杨素冰(1);张相良(2)

10.12074/201712.00536V1

肿瘤学临床医学基础医学

miR-409-3p胃癌预后

杨素冰(1);张相良(2).高精度腹腔灌注化疗患者血清中miR-409-3p表达水平与胃癌预后的关系[EB/OL].(2017-12-07)[2025-08-18].https://chinaxiv.org/abs/201712.00536.点此复制

评论